Meet with our product experts in one-on-one virtual sessions and get a deep insight into our API Pharma Products offerings.
Our experts will answer your questions, provide advice, and help you understand our product better.
Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products – Dr. Reddy’s is an active pharma API manufacturing company and pharmaceutical ingredient supplier for foremost formulators and offers a portfolio of products and services, including APIs, custom pharmaceutical services, generics, biosimilars, and differentiated formulations.
Our API business caters to leading innovator and generic companies across the US, Europe, Latin America, Japan, Korea, and other emerging markets. With deep technical strengths in the development of complex APIs such as steroids, peptides, complex long chain synthesis and oncology we consistently deliver high-quality APIs.
As a pharmaceutical API manufacturer, our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy’s operates in markets across the globe and top API manufactures in USA. Our major markets include – USA, Europe, India, Russia, and other CIS countries.
About Dr. Reddy’s API Business
250+ APIs
8 Manufacturing
Sites
More than 1880 drug master files
across global markets
50+ Pipeline molecules
(Filed + under development)
State-of-the-art R&D centers
in India, U.K., U.S. & Netherlands
Over 1300+ research scientists
working on various projects
Our Achievements
11/11/2021
Dr. Reddy's API team is a 2021 winner in - API Supplier of the year at Global generics & Biosimilars awards
11/11/2021
The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards
10/11/2021
Dr. Reddy's at CPHI 2021
21/01/2021
Best Supply Chain Team of the Year - Pharma- 2021
03/11/2020
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020
19/10/2020
Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of 'Excellence in Pharma: Sustainability'
Resources
API Manufacturing
Our API manufacturing facilities are operated in accordance with cGMP (ICH Q7) and are regularly inspected/audited by international regulatory authorities and numerous customers. We have eight commercial USFDA inspected production units, from which six production units are in India, and one in Mexico and the UK.
Research & Development
We have development facilities in Hyderabad, India and Cambridge, UK, as well as cGMP API manufacturing facilities in India, Mexico, and the UK. Our strong capabilities in synthetic chemistry, analytical chemistry, and process engineering, have helped us build a strong portfolio of small molecule APIs across niche areas including peptides, carbohydrates, prostaglandins, steroids, and highly potent APIs. This expertise has enabled us to develop a strong portfolio in key therapy areas including oncology, cardiovascular and central nervous system. Our capabilities include Complex Chemical Synthesis, HPAPIs, Peptides, Carbohydrates, and steroids.
Customer Service
Dr. Reddys provides its customers with a superior service experience with a platform called XCEED. XCEED will help manage the whole business process in real-time. From ordering samples to submitting and tracking their orders, XCEED provides convenience and transparency by providing a platform to interact with Dr. Reddy's interdisciplinary support team that helps in the timely delivery of the APIs closely.
Regulatory
Dr Reddy’s has an unmatched global regulatory expertise focused on international markets. Our top- class quality and industry-leading compliance are designed to ensure our products meet stringent requirements globally. Our Regulatory Affairs (RA) team is one of the strongest in the industry with a dedicated team of more than 50 experts in regulatory affairs. Our team of regulatory experts understands the complex issues associated with regulatory agencies and assists in the approval of each complex API by analyzing the latest regulatory trends, quality requirements through active monitoring and proactive assessment of potential risks.
Dr. Reddy's API business supplies high-quality, affordable APIs to leading generic formulations manufacturers and is the preferred API supplier to pharma companies worldwide. Dr. Reddy's API business thrives on the deep technical strengths proven over the last three decades in developing and manufacturing complex APIs.
The API division is strategically working towards becoming the number 1 API company in the world by focusing on strong innovation, global footprint, and exceptional customer service.
Selecting a world-class API is one of the most critical decisions a pharmaceutical manufacturer will make. So, choose your API wisely. To know more about the portfolio of our APIs and its services place a query or contact our team at: api@drreddys.com
免责声明
本目錄中的任何信息（包括對任何產品或服務的任何引用）均不構成銷售要約，或被解釋為代表銷售要約。受有效專利保護的產品不提供或供應用於商業用途。但是，只要存在此類監管豁免，就可以出於監管提交的目的提供此類產品的研究數量。買方應對各自市場的專利方案進行獨立評估，並承擔所有與專利相關的責任。在印度受有效專利保護的產品不可用於商業用途，但可用於第 107A 節。